Federated Hermes’s Clementia Pharmaceuticals Inc. CMTA Stock Holding History

Federated Hermes’s Portfolio CMTA Stock Details CMTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-190,200	Closed	-$4.96M	–	2289
2019 Q1	$4.96M	Sell	190,200 -613,600	-76%	-$11.5M	0.01%	789
2018 Q4	$9.45M	Buy	803,800 +125,000	+18%	+$1.55M	0.03%	513
2018 Q3	$7.57M	Hold	678,800	–	–	0.02%	675
2018 Q2	$8.93M	Hold	678,800	–	–	0.03%	495
2018 Q1	$10.3M	Hold	678,800	–	–	0.03%	414
2017 Q4	$12.9M	Buy	+678,800	New	+$11.4M	0.04%	372

Federated Hermes's CMTA Position: Q2 2019 in Review

Federated Hermes sold out of Clementia Pharmaceuticals Inc. (CMTA) in Q2 2019, closing a stake of 190,200 shares — an estimated $4.96M sold.

Federated Hermes first reported a position in CMTA in Q4 2017 and held it in 6 quarters. The position peaked at $12.9M in Q4 2017. 0 funds tracked by Wall St. Rank hold CMTA as of Q2 2019.

Federated Hermes reported no remaining Clementia Pharmaceuticals Inc. position as of Q2 2019 after selling out during the quarter.
Federated Hermes sold 190,200 Clementia Pharmaceuticals Inc. shares in Q2 2019, an estimated $4.96M.
Federated Hermes first reported a position in Clementia Pharmaceuticals Inc. in Q4 2017 and held it in 6 quarters.
Federated Hermes's Clementia Pharmaceuticals Inc. position peaked at $12.9M in Q4 2017.
0 funds tracked by Wall St. Rank held Clementia Pharmaceuticals Inc. as of Q2 2019.

Based on Federated Hermes's 13F filing for Q2 2019, filed 14 Aug 2019.